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Endocytosis mediates the cellular uptake of micronutrients and cell surface proteins. Fast
Endophilin-mediated endocytosis, FEME, is not constitutively active but triggered upon
receptor activation. High levels of growth factors induce spontaneous FEME, which can be
suppressed upon serum starvation. This suggested a role for protein kinases in this growth
factor receptor-mediated regulation. Using chemical and genetic inhibition, we find that Cdk5
and GSK3β are negative regulators of FEME. They antagonize the binding of Endophilin to
Dynamin-1 and to CRMP4, a Plexin A1 adaptor. This control is required for proper axon
elongation, branching and growth cone formation in hippocampal neurons. The kinases also
block the recruitment of Dynein onto FEME carriers by Bin1. As GSK3β binds to Endophilin, it
imposes a local regulation of FEME. Thus, Cdk5 and GSK3β are key regulators of FEME,
licensing cells for rapid uptake by the pathway only when their activity is low.
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C lathrin-mediated endocytosis (CME) is the major uptakepathway in resting cells1,2, but additional Clathrin-independent endocytic (CIE) routes, including fast
Endophilin-mediated endocytosis (FEME), perform specific
functions or internalize specific cargoes3,4. FEME is not con-
stitutively active but is triggered upon the stimulation of selected
cell surface receptors by their ligands5. These include G-protein
coupled receptors (e.g., β1-adrenergic receptor, hereafter β1AR),
receptor tyrosine kinases (e.g., epidermal growth factor receptor,
EGFR) or cytokine receptors (e.g., Interleukin-2 receptor)5. In
resting cells, FEME is primed by a cascade of molecular events
starting with active, GTP-loaded, Cdc42 recruiting CIP4/FBP17
that engage the 5′-phosphatase SHIP2 and Lamellipodin (Lpd).
The latter then concentrates Endophilin into clusters on discrete
locations of the plasma membrane6. In absence of receptor acti-
vation, the clusters dissemble quickly (after 5–15 s) upon local
recruitment of the Cdc42 GTPase-activating proteins RICH1,
SH3BP1, or Oligophrenin6. New priming cycles start nearby,
constantly preparing the plasma membrane for FEME. Upon
activation, receptors are quickly sorted into pre-existing Endo-
philin clusters that then bud to form FEME carriers, which are
Clathrin-negative, Endophilin-positive assemblies (EPAs) found
in the cytosol. The entire process takes 4–10 s6. These FEME
carriers travel rapidly to fuse with early endosomes and deliver
their cargoes. While it is well established how FEME carriers are
produced, we know very little about the regulation of the path-
way. Grown in their respective full-serum media, different cell
types display various levels of FEME. And the removal of growth
factors (serum starvation) shuts down the pathway. Thus, we
reasoned that such growth factor receptor-mediated regulation
could be controlled by protein kinases. Here, we show that Cdk5
and GSK3β are negative regulators of FEME. Their chemical or
genetic inhibition is sufficient to activate FEME promptly in
resting cells, and upon addition of dobutamine, to boost the
production of FEME carriers containing β1AR. The kinases
inhibit at least three steps: endophilin binding and recruitment of
CRMP4 and Dynamin-1 and Bin1 binding and recruitment of
Dynein. This regulates cargo sorting, membrane scission, and
FEME carrier transport onto microtubules. In hippocampal
neurons, this control is required for proper growth cone forma-
tion, axon elongation, and branching.
Results
Different cell types display various levels of FEME activity.
Some cell types display spontaneous FEME when grown in their
regular culture medium, while others do not. Normal RPE1 cells,
primary human dermal fibroblasts (hDFA) and human umbilical
vein endothelial cells (HUVEC) exhibited robust FEME in resting
cultures grown in regular media (~5 to 15 EPAs per 100 μm2,
Suppl. Fig. 1a–d). In contrast, HeLa, HEK293, and BSC1 cells
displayed very little spontaneous FEME. In these cells, not only
was FEME identified in a minority of cells, but also a low number
of FEME carriers were detected in those that were active (~1 to 3
EPAs per 100 μm2, near the leading edge, Fig. S1a–c). This is not
to be confused with FEME priming events (Endophilin short-
lived clustering without subsequent carrier budding), which are
identified by live-cell microscopy by the growing and dis-
appearance of Endophilin spots (blinking) without any lateral
movements. For example, BSC1 cells display abundant priming
(clustering of Endophilin) but very little spontaneous FEME (fast
moving EPAs into the cytosol)5,6. However, within a same cul-
ture, not all the cells displayed FEME (the maximum was ~60% of
HUVEC cells, Fig. S1a, b, d).
In all cell types tested, FEME was enhanced by the addition of
10% serum to complete medium, as shown by an increase in the
percentage of cells showing FEME activity as well as increase in
EPA production (Suppl. Fig. 1b, c). Because FEME was inactive in
cells starved of serum5 (i.e., without growth factors), we looked
for kinases that may regulate its activity. Other endocytic
pathways are regulated both positively and negatively by multiple
protein kinases7–10. Thus, we investigated whether phosphoryla-
tion would trigger or hinder FEME and looked for mechanisms
that may control the level of FEME activity.
Inhibition of Cdk5 and GSK3 activates FEME. Small molecule
inhibitors were used to screen the role of kinases known to reg-
ulate membrane trafficking and actin cytoskeleton dynamics
(which is required for FEME). The compounds used were
amongst the best-reported inhibitors for each kinase11,12. Four
concentrations were tested (10, 100 nM and 1, 10 μM), with the
minimum effective concentrations for each compound selected
for further measurements. Small compounds were chosen because
they can be used for short timeframes (minutes), limiting indirect
effects on other kinases and long-term cumulative trafficking
defects induced by gene depletion. The cells were treated for 10
min at 37 °C with the inhibitors diluted in regular growth med-
ium containing 10% serum, and then fixed with pre-warmed
paraformaldehyde solution (to preserve FEME carriers, see
“Methods” section). RPE1 cells were used because they display
robust spontaneous FEME when grown in regular medium
(Fig. 1a, normal). This allowed identification of kinase inhibitors
that either decreased or increased FEME. Normal FEME activity
(that is, similar to DMSO-treated cells) was given one mark
during scoring (Fig. 1a). Positive and negative controls (dobuta-
mine and PI3Ki, respectively5) benchmarked the scoring for
decreased (zero mark) and increased (two marks) FEME (Fig. 1a).
Decreased FEME was assigned for samples with >80% reduction
in the number of EPAs, in at least 50% of the cells. Increased
FEME was attributed to samples with >200% elevation in the
number of EPAs, in at least 50% of the cells.
The stringent criteria used likely missed mild modulations but
revealed robust regulators of FEME. Inhibition of CaMKK1 and
2, SYK, FAK, or mTORC1/2 reduced FEME significantly (Fig. 1b),
but this was not investigated further in the present study.
Conversely, acute inhibition of Cdk5, GSK3 or p38 increased
spontaneous FEME (Fig. 1b). Even though the three inhibitors for
Cdk5 also inhibited other cyclin-dependent kinases, we were able
to exclude a role for Cdk1 and 2 as inhibitors of these kinase
failed to enhance FEME activity (Fig. 1b), and because Cdk7 and
9 are nuclear13. The role for p38 in FEME was not investigated
further at this stage. Cdk5 inhibitors, Dinaciclib, and Roscovitine,
and GSK3 inhibitors, BIO and CHIR-99021, were validated to
enhance FEME in a dose-dependent manner (Fig. 1c), confirming
that these kinases inhibit FEME in resting cells. Inhibition of
Cdk5 and GSK3 increased productive FEME, as a larger number
of endocytic carriers contained β1AR upon its activation by
dobutamine (Fig. 1d). This is also coherent with the overlap of the
binding sites of heterotrimeric G proteins and Endophilin on
β1AR14,15.
Endophilin recruits GSK3β to regulate FEME locally. GSK3α
and β kinases require prior phosphorylation of their substrates by
several other kinases (e.g., PKA, AMPK, CK1/2, and Cdk5). GSK3
docks onto these primed sites and then phosphorylates nearby
Serines or Threonines, a few amino acids away16. The kinase is
auto-inhibited by phosphorylation at its N-terminus (Ser 9 in
GSK3β, pS9-GSK3β hereafter), which then occupies its docking
site and thus blocks its interaction with substrates. This phos-
phorylation on GSK3 is mediated by many kinases that are acti-
vated by growth factor receptor signaling including AKT and
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ERK17,18. In absence of growth factors (such as upon serum
starvation), pS9-GSK3β is reduced, relieving the auto-inhibition of
the kinase18. Consistently, we observed reduced levels of inactive
pS9-GSK3β and depression of FEME in cells starved for growth
factors (Fig. 2a, b). In contrast, stimulating cells with an additional
10% serum (20% final) for 10min inactivated the kinase (as
deduced from the high levels of inactive pS9-GSK3β), and acti-
vated FEME beyond resting levels (Fig. 2a, b). There was a linear
correlation (r2= 0.99) between the levels of inactive GSK3β and
the numbers of FEME carriers within the same cells (Fig. 2a, b).
However, activation of other receptors (e.g., β1AR with dobuta-
mine) activated FEME in resting cells without measurable changes
in GSK3β activity (Fig. 2b, +dobutamine, middle). There was a
maximum level of FEME activity, as addition of dobutamine on
cells that were previously activated with 10% extra serum did not
increase the number of EPAs further (Fig. 2b, +dobutamine,
right). When GSK3β activity was high (starved cells), dobutamine
could not activate FEME (Fig. 2b, +dobutamine, left). There was a
poor correlation (r2= 0.67) between the kinase activity and FEME
stimulation by dobutamine, suggesting that GSK3β acts upstream,
imposing a cap on FEME that can be quickly lifted upon receptor
activation.
As mass spectrometry detected GSK3β amongst the proteins
immunopurified by anti-Endophilin antibodies (Suppl. Fig. 2a and
Source Data file), we further characterized its binding to
Endophilin. We found that GSK3β, but not α, bound to the SH3
domain of Endophilin but not that of the closely related N-BAR
domain protein Bin1 (Fig. 2c). Consistently with the detection of
GSK3β from resting but not FBS-stimulated extracts, (Suppl.
Fig. 2a), the binding was not detected in extracts of cells that were
inhibited for Cdk5 and GSK3 prior to lysis (Fig. 2c). Furthermore,
GSK3β was detected on priming Endophilin spots at the leading
edge but reduced on FEME carriers following inhibition (Fig. 2d).
In contrast, inactive GSK3β was detected more on EPAs than on
priming spots at the leading edge (Fig. 2d). Consistent with binding
data, Cdk5 and GSK3 inhibitors blocked the recruitment of both
total and inactive GSK3β (Fig. 2d). Thus, we concluded that
Endophilin recruits GSK3β to inhibit FEME locally. Importantly,
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Fig. 1 Acute inhibition of Cdk5 and GSK3 activates FEME. a Scoring criteria used in the kinase screen. Representative images of decreased, normal, and
increased FEME in resting human RPE1 cells treated with 10 μM dobutamine, 10 μM DMSO, and 10 nM GDC-0941 (PI3Ki), respectively. Arrowheads point
at FEME carriers. Decreased FEME was assigned for samples with >80% reduction in the number of cytoplasmic Endophilin-positive assemblies (EPAs), in
at least 50% of the cells. Increased FEME was attributed to samples with >200% elevation in the number of EPAs, in at least 50% of the cells. The
corresponding scoring marks were 0, 1, and 2, respectively. Scale bar, 5 μm. b Kinase screen using small compound inhibitors. RPE1 cells grown in complete
medium were incubated for 10min at 37 °C with the following inhibitors: DMSO, (vehicle); dobutamine, 10 μM (positive control); Dinaciclib (Cdk1/2/5/
9i), 1 μM; CHIR-99041 (GSK3i1), 1 μM; BIO (GSK3i2), 1μM; Roscovitine (Cdk1/2/5i), 1 μM; PHA-793887 (Cdk2/5/7i), 100 nM; VX-745 (p38i), 10 μM;
JNK-IN-8 (JNKi), 1 μM; staurosporine (broad kinases), 1 μM; GNE-7915 (LRRK2i), 1 μM; AZ191 (DYRK1Bi), 10 μM; GSK2334470 (PDKi), 10 μM; PF-
4708671 (p70S6Ki), 10μM; AZ191 (DYRKi), 10 μM; AZD0530 (broad SRCi), 1 μM; TAK-632 (panRAFi), 10 μM; GW 5074 (CRAFi), 1 μM; PD0332991
(Cdk4/6i), 1 μM; MK2206 (AKTi), 1 μM; GDC-0879 (BRAFi), 1 μM; CX-4945 (CK2i), 1 μM; ZM 447439 (AurA/AurBi), 1 μM; RO-3306 (Cdk1i), 100 nM; BI
2536 (PLKi), 1 μM; PD0325901 (MEKi), 100 nM; Genistein (Y-kinases), 1 μM; Purvalanol A (Cdk1/2/4i), 100 nM; MLR 1023 (LYNi), 1 μM; P505-15 (SYKi),
100 nM; CDK1/2 inhibitor III (Cdk1/2i), 100 nM; KT 5720 (PKAi), 100 nM; BI-D1870 (p90RSKi), 100 nM; D4476 (CK1E), 1 μM; PF-4800567 (CK1Ei), 1 μM;
SCH772984 (ERKi), 100 nM; STO609 (CaMKK1/2ii), 100 nM; P505-15 (SYKi), 1μM; PND-1186 (FAKi), 100 nM; Torin 1 (mTORC1/2i), 10 μM and GDC-
0941 (PI3Ki), 100 nM (negative control). Histograms show the mean ± SEM from 12 well per condition, from three independent biological experiments.
Statistical analysis was performed by one-way ANOVA. ns non significant; *P < 0.05, **P < 0.01. c Number of FEME carriers (EPAs) upon titration of CHIR-
99021, BIO, Roscovitine and Dinaciclib. Dobutamine and GDC-0941 were used as positive and negative controls, respectively. Plots show the mean ± SEM
from three cells per condition and per timepoint, from three independent biological experiments. d β1-adrenergic receptor (β1AR) uptake into FEME carriers
in RPE1 cells pre-treated with 5 μM CHIR-99021 (GSK3i) for 5 min, followed by 10 μM dobutamine for 4min or not (resting). Scale bars, 5 μm. Histograms
show the mean ± SEM of the number of FEME carriers (LHS: left hand side) and the number of FEME carriers positive for β1AR per 100 μm2 (RHS: right
hand side) (n= 30 cells per condition, from biological triplicates). Arrowheads point at FEME carriers. Statistical analysis was performed by two-way
ANOVA. ns non significant; *P < 0.05, **P < 0.01, ***P < 0.001.
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when comparing spontaneous FEME in different cell types, we
found that levels of the inactive pS9-GSK3β were inversely
correlated with the proportion of resting cells displaying sponta-
neous FEME (r2= 0.91, Fig. 2e, f). But there was no correlation
between the kinase activity and the amounts of EPAs produced by
spontaneous FEME in these resting cells (r2= 0.61, Fig. 2g).
Cdk5 and GSK3β work in synergy to inhibit FEME. Because
dobutamine did activate FEME robustly, regardless of basal
GSK3β activity, we hypothesized that there must be another layer
of regulation upstream or parallel to the kinase. Given the
requirement of a priming kinase for GSK3 action16,19, we tested a
potential synergy with Cdk5. Genetic inhibition of either Cdk5 or
BSC1 inset




















































































































































































































































































































































































Fig. 2 Endophilin recruits GSK3β for local regulation of FEME. a Confocal images showing levels of phosphorylated Ser9 GSK3β (pS9-GSK3β) inactive
kinase, and colocalization with Endophilin in cells starved of serum for 1 h (serum starved), grown in 10% serum medium (resting) or stimulated with
additional serum for 10min (+10% serum). Arrowheads point at cytoplasmic Endophilin-positive assemblies (EPAs), FEME carriers. Scale bar, 20 μm (main)
and 10 μm (inset). b Correlation between the number of EPAs and pS9-GSK3β levels (single cell measurements) in cells that were starved of serum for 1 h
(starved), grown in 10% serum medium (resting) or stimulated with additional serum for 10min (+10% serum), followed by the addition of 10 μM
dobutamine for 4min (red data points) or not (blue data points). Plots show the mean ± SEM from five cells per condition from three independent biological
experiments. Linear regression fit is indicated as r2 values. Statistical analysis was performed by one-way ANOVA. ns non significant, ***P < 0.001.
c Pull-down experiments using beads with GST-SH3 domains of Endophilin A2 or Bin1, in resting cells or cells treated with 5 μMDinaciclib (Cdk5i) and CHIR-
99021 (GSK3i) for 10min. GST beads were used as negative control. Bound GSK3β was detected using an antibody that detects both GSK3α and GSK3β.
Histograms show the mean ± SEM of GSK3β binding, normalized to resting GST levels from three independent biological experiments. Statistical analysis
was performed by one-way ANOVA. ns non significant, ***P < 0.001. d Colocalization of total and phosphorylated Ser9 GSK3β and Endophilin in cells treated
with 5 μM Cdk5 and GSK3 inhibitors for 10min, or not (resting). Arrowheads point at Endophilin spots and FEME carriers. Scale bars, 5 μm. Histograms
show the mean ± SEM of Endophilin spots at the leading edge of cells (spots within 1 μm of cell edges, LHS: left hand side) and on EPAs (RHS: right hand
side) positive for total or pS9-GSK3β. n= 50 spots or EPAs per condition, from three independent biological experiments. Statistical analysis was performed
by one-way ANOVA. ns non significant, ***P < 0.001. e Confocal images showing levels of pS9-GSK3β and colocalization with Endophilin in resting HeLa,
HEK, BSC1, RPE1, hDFA, or HUVEC grown in their respective full serum media. Arrowheads point at FEME carriers. Scale bar, 20 μm (main) and 10 μm
(inset). f Correlation between the percentage of cells displaying active FEME and their pS9-GSK3β levels (single cell measurements) in the indicated resting
cell types. Plots show the mean ± SEM from five cells per condition from three independent biological experiments. Linear regression fit is indicated as r2
value. g Correlation between the number of EPAs and pS9-GSK3β levels (single cell measurements) in the indicated resting cell types. Plots show the mean
± SEM from five cells per condition from three independent biological experiments. Linear regression fit is indicated as r2 value.
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GSK3α/β increased spontaneous FEME in resting cells (Fig. 3a, b
and Suppl. Fig. 2b), and, conversely, in individual cells, the
expression levels of the kinases correlated negatively with FEME
activity (r2= 0.97, Fig. 3b). This confirmed the data obtained with
the kinase inhibitors, but also suggests that as long as the kinases
are inactive, FEME is elevated, as gene depletion by RNAi persists
for several days. RNAi rescue with high levels of either wild type
(WT) or constitutively active (CA) forms of the kinases were
sufficient to suppress FEME. However, dominant-negative forms
(DN) of either Cdk5 or GSK3β did not rescue the effect of the
depletion of the endogenous kinases (Fig. 3a, c). The dual inhi-
bition of Cdk5 and GSK3β occasioned a synergistic activation of
FEME (Figs. 1d and 3d, e), driving not only cargo loading but also
FEME carrier budding and lateral movement within the
cytoplasm.
Cdk5 and GSK3β regulate dynamin recruitment onto FEME
carriers. Dynamin mediates the budding of FEME carriers5 and is









































































































































































































































Fig. 3 Cdk5 and GSK3β act in synergy to control FEME. a Confocal microscopy images of control RPE1 cells (control), or cells in which Cdk5 or GSK3α and
β had been knocked-down using RNAi (CDK5 KD or GSK3α/β DKD, respectively) cells. Wild-type (WT), constitutively active (CA) or dominant negative
(DN) forms of Cdk5 or GSK3β (green) were overexpressed in a knock-down background and endogenous Endophilin (red) was immunostained, as
indicated. All cells were stimulated with +10% FBS (20% final) for 10 min prior to fixation. Arrowheads point at FEME carriers. Scale bars, 20 μm.
b Correlation between the number of EPAs and their Cdk5 or GSK3β levels (single cell measurements) in control, Cdk5 or GSK3α/β depleted cells, as
indicated. Plots show the mean ± SEM from five cells per condition from three independent biological experiments. Linear regression fit is indicated as r2
value. c Number of EPAs in RPE1 cells treated as indicated in a and d. Histograms show the mean ± SEM from three independent biological experiments
(n= 50 per condition). Statistical analysis was performed by one-way ANOVA. ns, non significant; *P < 0.05, **P < 0.01, ***P < 0.001. d Confocal
microscopy images of resting control RPE1 cells (control), Cdk5 (CDK5 KD), GSK3α and β (GSK3α/β DKD) or Cdk5 and GSK3α/β (Cdk5+GSK3α/β TKD)
knocked-down cells. Arrowheads point at FEME carriers. Scale bar, 20 μm (main) and 10 μm (inset). e Kymographs from cells expressing low levels of
Dynamin1-EGFP and EndophilinA2-RFP, treated with CHIR-99021 (GSK3i) or Dinaciclib (Cdk5i) as indicated and imaged at 2 Hz. Arrowheads point at
FEME carriers. Kymographs are representative of at least three captures from biological triplicates. Histograms show the mean ± SEM from three
independent biological experiments (n= 3 cells per condition). Statistical analysis was performed by one-way ANOVA. *P < 0.05, ***P < 0.001.
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subsequently on Ser774 by GSK3β (Fig. 4a). This blocks the
function of Dynamin in CME but is required for activity-
dependent bulk endocytosis in synapses8,9. Consistent with
proximity of the phosphorylated residues to the binding site of
Endophilin on Dynamin21,22, the inhibition of both Cdk5 and
GSK3 increased Dynamin recruitment onto budding FEME car-
riers (Figs. 3e and 4c, d). Furthermore, mutation of the Cdk5 and
GSK3β phosphorylation sites on Dynamin also increased its
binding to Endophilin (Fig. 4b). As the single inhibition of either
Cdk5 or GSK3β was sufficient to relieve FEME from their control
(even though the other kinase should not be affected), we con-
cluded that Cdk5 acts upstream of GSK3β, and that other kinases
may prime GSK3β in absence of Cdk5. The synergy of their
inhibition suggested that they hamper FEME at several steps,
beyond Dynamin recruitment.
Cdk5 blocks the binding of Endophilin to CRMP4 and the
sorting of PlexinA1 into FEME carriers. Amongst proteins
known to be phosphorylated by Cdk5 and GSK3β is collapsin
response mediator protein 4 (CRMP4)23. We recently identified
CRMP1, 3, and 4 in pulldown experiments using Endophilin SH3
domains6. CRMP1 to 5 form homo-tetramers and hetero-
tetramers acting as adaptors during cell guidance mediated by
Plexin A1 (Fig. 5a), and mediate cytoskeletal remodeling upon
Semaphorin 3A or 6D sensing24–26. Cdk5 phosphorylates
CRMP4 at Ser 522, which primes GSK3β-mediated phosphor-
ylation at the positions Thr 509, Thr 514, and Ser 51823 (Fig. 5a).
The phosphorylation of CRMP4 perturbs its binding to micro-
tubules and actin and CRMP4 is critical for proper neuronal
development in both zebrafish and mice27,28. Inhibiting Cdk5, or
overexpressing the non-phosphorylatable mutant CRMP4-S522A,
increased CRMP4 binding to Endophilin, whereas a phospho-
mimetic mutation S522D had the opposite effect (Fig. 5b, c, e, f
and Suppl. Fig. 3a, b, d). Endophilin recruits cargoes into FEME
carriers through the binding of its SH3 domain to proline rich
motifs present in cargo adaptors or cytoplasmic tails of
receptors5. Point mutations P526A or R525E, but not P502A,
abolished the interaction with Endophilin (Fig. 5d and Suppl.
Fig. 3c), thus establishing that the binding motif for Endophilin
on CRMP4 is the proline-rich motif (aa 523-529) proximal to Ser
522 (Fig. 5a). The sites phosphorylated by GSK3β are several
amino acids away from that motif, explaining why GSK3 inhi-






























IB: anti-myc or anti-EGFP
a
c


































































































































































































Fig. 4 Cdk5 and GSK3β regulate Dynamin recruitment onto FEME carriers. a, Human Dynamin-1 sequence (aa 770-794). Amino acids phosphorylated by
GSK3 β (S774) and by Cdk5 (S778) are shown in blue and red, respectively. The proline-rich motif to which Endophilin is known to bind to is shown in
orange (underlined). b, Co-immunoprecipitation of Endophilin A2-Myc and Dynamin1-EGFP wild-type (WT), or non-phosphorylatable mutants S774A or
S778A. Inputs (I) correspond to 0.5% of the cell extracts), and bound fractions (B) to 90% of material immunoprecipitated. Right, Histograms show the
mean ± SEM from three independent biological experiments. Statistical analysis was performed by one-way ANOVA. *P < 0.05. c Pull-down experiments
using beads with GST-SH3 domains of Endophilin A2 or Bin1, in resting cells or cells treated with 5 μM Dinaciclib (Cdk5i) and CHIR-99021 (GSK3i) for 10
min. GST beads were used as negative control. X labels a lane that was not used in this study. Inputs correspond to 4% of cell extracts. Right, histograms
show the mean ± SEM of Dynamin-1 binding, normalized to resting GST levels from three independent biological experiments. Statistical analysis was
performed by two-way ANOVA. *P < 0.05. d Recruitment of endogenous Dynamin onto FEME carriers in RPE1 cells treated for 10min with 5 μM Dinaciclib
(Cdk5i) and/or CHIR-99021 (GSK3i) or not, followed by 10μM dobutamine for 4min. Arrowheads point at FEME carriers. Scale bars, 5 μm. Histograms
show the mean ± SEM from three independent biological experiments (n= 50 cells per condition). Statistical analysis was performed by one-way ANOVA.
***P < 0.001.
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(Fig. 5b and Suppl. Fig. 3a). However, inhibiting GSK3 increased
their colocalization in cells (Fig. 5f and Suppl. Fig. 3e), probably
through the broad activation of FEME. Consistent with the bio-
chemical data, mutations in CRMP4 inhibiting its binding to
Endophilin abrogated localization of CRMP4 on FEME carriers,
even upon co-overexpression (Fig. 5e and Suppl. Fig. 3d).
In HUVEC cells, which express CRMP4 and Plexin A1
endogenously29, both Cdk5 and GSK3 inhibition enhanced the
recruitment of endogenous CRMP4 onto FEME carriers and the
uptake of Plexin A1 upon Semaphorin 3A stimulation (Fig. 5f, g
and Suppl. Fig. 3e–g). However, the dual inhibition of Cdk5 and
GSK3 did not induce a synergistic effect on Endophilin-CRMP4
colocalization nor PlexinA1 uptake (Fig. 5f, g and Suppl. Fig. 3e, g).
Similarly to other receptors (e.g., EGFR)5, PlexinA1 can be
internalized both via FEME and CME to enter cells (Suppl. Fig. 3f),
perhaps from different cellular location. At the leading edge of
HUVEC cells, where FEME is prominent (Suppl. Fig. 1d), uptake
of PlexinA1 upon Cdk5 inhibition was primarily through FEME
carriers (Fig. 5g and Suppl. Fig. 3g).
Plexin A1 senses repulsive axon guidance cues such as
Semaphorin 3A, which repels axons and inhibits axon elongation
and branching30–32. Upon binding to secreted Semaphorin 3A,
Plexin triggers local actin and microtubule depolymerization,
thereby causing axon growth cone (AGC) collapse and abortion
of axon branching32. As FEME cargoes accumulate at the plasma
membrane upon inhibition of the pathway5, we reasoned that
unlinking Plexin A1 from FEME upon overexpression of the
CRMP4 mutant that cannot bind to Endophilin would sensitize
neurons to the repelling action of Sempahorin 3A.
At AGCs of mouse hippocampal neurons, we found that
endogenous Plexin A1 located within FEME carriers in a
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Fig. 3h). Overexpression of the CRMP4 mutant that cannot bind
to Endophilin (R525E) reduced axon length in mouse hippo-
campal neurons in comparison to WT CRMP4 (Fig. 5h and
Suppl. Fig. 3i). Unlinking Plexin A1 from FEME upon CRMP4-
R525E overexpression also caused a reduction in interstitial axon
branching (also called collateral branching) as well as constitutive
collapse of axon growth cones, even in absence of additional
Semaphorin 3A (Fig. 5i, j and Suppl. Fig. 3i). The increased AGC
collapse and strong axon growth and branching defects may be
due to increased levels of Plexin A1 remaining at the cell surface,
as its internalization is hampered by the absence of FEME
carriers. At constant Semaphorin 3A concentrations, this would
render neurons more sensitive to its repulsive activity.
Conversely, expression of the CRMP4 mutant that cannot be
phosphorylated by Cdk5 (S522A) had no effect on axon
branching. but protected AGCs from Semaphorin 3A-induced
collapse (Fig. 5i, j and Suppl. Fig. 3i).
The CRMP4-S522A mutant likely caused a similar increase in
Plexin A1 uptake compared to the one measured in HUVEC
(Fig. 5g). By having less Plexin A1 on their surface (due to
increased FEME), neurons expressing the S522A mutant would
become less sensitive to the repelling action of Semaphorin 3A.
Altogether, these experiments established that Cdk5 controls the
binding of Endophilin to CRMP4, thereby regulating the uptake
of Plexin A1 into FEME carriers and proper axon branching and
extension.
To confirm these results with other axon guidance receptors,
we tested interaction of receptors comprising putative proline-
rich motifs in their cytoplasmic tails. We found that Endophilin
binds to Semaphorin 6A, Semaphorin 6D, and ROBO1
cytoplasmic tails (Suppl. Fig. 4a). Roundabout (ROBO) receptors
bind to Slit ligands to mediate cell guidance, including axon
repulsion33. Recently, Endophilin was found to mediate the
uptake of ROBO1 and VEGFR2 via a Clathrin-independent
pathway reminiscent to FEME34. We confirmed that Slit1 enters
cells via FEME carriers (Suppl. Fig. 4b) and its cellular uptake was
strongly reduced in FEME-deficient but not in CME-deficient
cells (Endophilin triple knock-down, TKD, and AP2 knock-
down, respectively, Suppl. Fig. 4c). Upon binding to Slit, ROBO1
activates AKT, which in turn phosphorylates GSK3β on Ser9,
thereby de-activating the kinase in axons35,36. Consistently, acute
inhibition of GSK3β increased the uptake of Slit1 into FEME
carriers two-fold (Suppl. Fig. 4c). Thus, Cdk5 and GSK3β kinases
act at another level of FEME by controlling the sorting of cargoes,
such as PlexinA1 and ROBO1, into endocytic carriers.
Cdk5 and GSK3β control the recruitment of Dynein by Bin1
onto FEME carriers. As Cdk5 and GSK3 kinases regulate Dynein
activity and binding to cargoes37,38 and because FEME carriers
containing Shiga toxin rely on this microtubule motor for scission
and retrograde trafficking39,40, a role for the kinases in regulating
Dynein during FEME was explored. We confirmed that inhibiting
Dynein (with either the small inhibitor Ciliobrevin D41 or the
overexpression of the p50 dynamitin subunit of the dynactin
complex42) blocked FEME carrier budding and β1AR endocytosis
(Suppl. Fig. 5a, b). However, inhibition of Kinesin upon over-
expression of the TPR subunit43 had no effect (Suppl. Fig. 5a, b)
This is consistent with the role of microtubule motors in gen-
erating membrane tension, thus facilitating the scission of bud-
ding membrane carriers by Dynamin and BAR domain proteins
such as Endophilin44. Most FEME carriers were detected in the
vicinity of microtubules, and their mild depolymerization using
low doses (100 nM) of nocodazole stalled FEME carriers at the
plasma membrane (Fig. 6a). FEME carriers, produced in resting
cells upon acute Cdk5 and GSK3β inhibition, recruited Dynein
and travelled along microtubules (Fig. 6a–d). Dynein was
immunopurified together with Endophilin from cell extracts in
which Cdk5 was inhibited (Fig. 6e). To confirm that Dynein was
recruited onto FEME carriers produced upon Cdk5 and GSK3β
inhibition, immunoprecipitation was performed on membrane
fractions enriched in Endophilin but containing only small
amounts of other endocytic markers (Fractions 7 of sucrose
Fig. 5 Cdk5-mediated phosphorylation of CRMP4 inhibits the binding of Endophilin to CRMP4 and the sorting of Plexin A1 into FEME carriers. a Top,
diagram showing the recruitment of CRMP2-5 adaptor complex (CRMP4 highlighted in blue) to Plexin A1 upon stimulation with Semaphorin 3A. Bottom,
human CRMP4 protein sequence (aa 508–530). Amino acids phosphorylated by GSK3β (T509, T514, and S518) and by Cdk5 (S522) are shown in blue and
red, respectively. The Endophilin binding motif established in this study is shown in orange (underlined). b Co-immunoprecipitation of CRMP4-EGFP and
Endophilin A2-Myc from cells treated with 5 μM CHIR-99021 (GSK3i) or Dinaciclib (Cdk5i) as indicated. I, input (10% of the cell extracts), U, unbound
(10% of total) and B, bound fractions (80% of total), respectively. c Co-immunoprecipitation of CRMP4-EGFP wild-type (WT), S22D or S522A and
Endophilin A2-Myc. I, input (10% of the cell extracts), and B, bound fractions (90% of total), respectively. d Pull-down using GST-SH3 domains of
Endophilin A1, A2, or A3 and cell extracts expressing the indicated EGFP-tagged CRMP proteins. GST was used as negative control. Binding proteins were
detected by immunoblotting with an anti-EGFP antibody. input lanes correspond to 5% of the cell extracts. e Recruitment of EGFP-tagged CRMP4 WT,
S522A, S522D, or R525E onto FEME carriers (cytoplasmic Endophilin-positive assemblies, EPAs) in HUVEC cells. Arrowheads point at FEME carriers. Scale
bars, 5 μm. Histograms show the mean ± SEM from three independent biological experiments (n= 30 cells per condition). Statistical analysis was
performed by one-way ANOVA; ns non significant; *P < 0.05, **P < 0.01, ***P < 0.001. f Recruitment of endogenous CRMP4 onto FEME carriers in HUVEC
cells treated for 10 min with 5μM Dinaciclib (Cdk5i) and/or CHIR-99021 (GSK3i), or left untreated (resting). Arrowheads point at FEME carriers. Scale
bars, 5 μm. Histograms show the mean ± SEM from three independent biological experiments (n= 45 cells per condition). Statistical analysis was
performed by one-way ANOVA; ns non significant; ***, P < 0.001. g Endogenous Plexin A1 uptake into FEME carriers in HUVEC cells depleted of Endophilin
A1, A2, and A3 (Endophilin TKD), Cdk5 and GSK3α and β (CDK5+GSK3α/β TKD), CRMP4 (CRMP4 KD) or AP2 (AP2 KD) or pre-treated with Cdk5i and/
or GSK3i for 5 min. Cells were stimulated by 20 nM Semaphorin 3A (Sema3A) for 5 min in presence of 10 μg/mL anti-PlexinA1 antibodies (recognizing the
ectodomain of PlexinA1) or left untreated (resting). Arrowheads point at FEME carriers. Scale bars, 5 μm. Histograms show the mean ± SEM from three
independent biological experiments (n= 30 cells per condition). Statistical analysis was performed by one-way ANOVA; ns non significant; ***P < 0.001.
h Axon length of mouse hippocampal neurons expressing EGFP-CRMP4 wild type (WT), EGFP-CRMP4 S522A or EGFP-CRMP4 R525E mutants.
Histograms show the mean ± SEM of 73, 93, and 38 axons from 4 independent biological experiments, respectively. Statistical analysis was performed by
one-way ANOVA; *, P < 0.05, **, P < 0.01. i, Total (Left) or Interstitial (Right) axon branching of mouse hippocampal neurons expressing EGFP-CRMP4 wild
type (WT), EGFP-CRMP4 S522A or EGFP-CRMP4 R525E mutants. Histograms show the mean ± SEM of 12, 12 and 24 captures from 3 independent
biological experiments, respectively. Statistical analysis was performed by one-way (Right) two-way (Left) ANOVA; ns non significant; *P < 0.05, **P <
0.01. j Axon growth cone collapse in resting or neurons treated with 5 nM of semaphorin 3A and expressing EGFP-CRMP4 wild type (WT), EGFP-CRMP4
S522A or EGFP-CRMP4 R525E mutants. Scale bar, 20 μm. Histograms show the mean ± SEM of 13, 10, and 12 captures from three independent biological
experiments, respectively. Statistical analysis was performed by two-way ANOVA; ns non significant; ***P < 0.001.
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gradients, Fig. 6f). The material that was immuno-isolated from
such fractions likely contained FEME carriers, as they were rich in
Endophilin but also in lipids (detected by alcohol-free
Coomassie45, see “Methods” section) but devoid of Clathrin.
Importantly, Dynein was indeed immunopurified together with
Endophilin from such fractions (Fig. 6f, g).
We were intrigued by the presence of Bin1 in the immuno-
precipitated fractions, as we initially included it as a control (Bin1
is a N-BAR and SH3 domain-containing protein related to
Endophilin). To test for a potential role for Bin1 and other BAR
proteins in FEME, we screened our library containing 72 full-
length human BAR proteins tagged with EGFP6. But instead of
looking for BAR proteins colocalizing onto the transient
Endophilin clusters at the leading edge6, we focused on those
that localized onto FEME carriers produced upon FBS addition
(Fig. 7a). While ten BAR domain proteins (FAM92B, SH3BP1,
ASAP1, SNX9, SNX33, CIP4, Pacsin2, PSTPIP1, and Nostrin)
were significantly detected onto a subset (~15 to 45%) of EPAs,
only Amphiphysin, Bin1 and Bin2 located to the majority (>50%)
of FEME carriers (Fig. 7a, b). This partial localization of the ten
aforementioned BAR proteins could indicate that they play a role
only in discrete steps of FEME and/or interact with sub-
Fig. 6 Cdk5 and GSK3β inhibit Dynein recruitment onto FEME carriers. a, b Juxtaposition of FEME carriers and microtubules in HUVEC cells treated with
10 μM dobutamine for 4min, 5μM Dinaciclib (Cdk5i) and CHIR-99021 (GSK3i) for 10 min, but not upon mild depolymerization (using 100 nM nocodazole
for 10min prior to dobutamine stimulation). Arrowheads point at FEME carriers. Scale bar, 20 μm (main) and 10 μm (inset). Histograms show the mean ±
SEM from three independent biological experiments (n= 100 puncta per condition). Statistical analysis was performed by one-way ANOVA; ns non
significant; ***P < 0.001. c, d Recruitment of endogenous Dynein onto FEME carriers in HUVEC cells treated for 10 min with 5 μM Dinaciclib (Cdk5i) and
CHIR-99021 (GSK3i) or not, followed by 10 μM dobutamine for 4 min. Arrowheads point at FEME carriers. Scale bars, 5 μm. Histograms show the mean ±
SEM from three independent biological experiments (n= 50 cells per condition). Statistical analysis was performed by one-way ANOVA; ***P < 0.001.
e Co-immunoprecipitation experiments with EGFP or Endophilin A2-EGFP, in resting cells or cells treated for 30min with 5μM Dinaciclib (Cdk5i) and
CHIR-99021 (GSK3i). I, input (10% of the cell extracts), and B, bound fractions (90% of total), respectively. Histograms show the mean ± SEM from three
independent biological experiments. Statistical analysis was performed by one-way ANOVA; ns non significant; *P < 0.05. f Sucrose gradient (0–40%)
membrane isolation form RPE1 cells stimulated with 10% FBS (20% final) for 10min. Fractions were immunoblotted for Endophilin, Bin1, Dynein, Clathrin,
Caveolin-1, and Lamp-1. Fraction 7, containing high levels of Endophilin but low levels of Clathrin, Caveolin-1, and Lamp-1 was selected for subsequent
immuno-precipitation. g Anti-Endophilin immuno-precipitation from fraction seven samples. Immunoblots measured the levels of Endophilin, Bin1, Dynein,
Clathrin and lipids (detected using alcohol-free Coomassie45, see “Methods” section) in input (5% of cell extracts), washes (10% of total), unbound (10%
of total), and bound (50% of total) samples. Histograms show the mean ± SEM from three independent biological experiments.). Statistical analysis was
performed by one-way ANOVA; *P < 0.05, **P < 0.01, ***P < 0.001.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-22603-4 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:2424 | https://doi.org/10.1038/s41467-021-22603-4 |www.nature.com/naturecommunications 9


















































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 7 Bin1 recruits Dynein onto FEME carriers. a Colocalization of named EGFP-tagged BAR proteins on FEME carriers marked by endogenous Endophilin
in BSC1 cells stimulated with additional 10% serum for 10 min prior to fixation. Histograms show the mean ± SEM from three independent biological
experiments (n > 100 puncta per condition). Statistical analysis was performed by one-way ANOVA; NS non significant; P values as indicated. b
Colocalization of Bin1-EGFP on FEME carriers marked by endogenous Endophilin in BSC1 cells stimulated with additional 10% serum for 10 min prior to
fixation. Arrowheads point at FEME carriers. Scale bar, 20 μm (main) and 10 μm (inset). c Colocalization of endogenous Bin1 and Endophilin upon
stimulation with dobutamine, after treatment with 5 μM Dinaciclib (Cdk5i) and CHIR-99021 (GSK3i) for 10 min, or in cells depleted of Bin1 Amphiphysin
(Amph+ Bin1 DKD). Arrowheads point at FEME carriers. Scale bars, 5 μm. Histograms show the mean ± SEM from three independent biological
experiments (n > 150 puncta per condition). Statistical analysis was performed by one-way ANOVA; *P < 0.05, ***P < 0.001. d Pull-down experiments
using beads with GST-SH3 domains of Endophilin A2 or Bin1, in resting cells or cells treated with extra 10% FBS for 10 min. GST beads were used as
negative control. Inputs correspond to 4% of cell extracts. Bottom, histograms show the mean ± SEM of Dynein binding, normalized to resting GST levels
from three independent biological experiments. Statistical analysis was performed by two-way ANOVA; ns non significant; ***P < 0.001. e Colocalisation
between Bin1 and Dynein in cells stimulated with extra 10% serum (top), and between endophilin and dynein upon Amphiphysin/Bin1 double knock-down
(DKD)(bottom). Arrowheads point at FEME carriers. Scale bars, 5 μm. Histograms show the mean ± SEM from three independent biological experiments
(n > 50 puncta per condition). Statistical analysis was performed by one-way ANOVA; ***, P < 0.001. f Model: multi-layered regulation of FEME by Cdk5
and GSK3β: 1) obstruction of CRMP4 binding to Endophilin and thus PlexinA1 sorting into FEME carriers upon Semaphorin 3A stimulation, 2) inhibiton of
Dynamin recruitment onto FEME carriers, thus inhibiting vesicle budding and 3) hinderance of Dynein recruitment by Bin1, thereby reducing FEME carriers
movement. GSK3β binds to Endophilin and acts locally to hold off FEME. In cells exposed to growth factors, PI3K-mediated signaling activates AKT and
other kinases that controls GSK3β activity, and thus license cells for FEME.
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populations of FEME carriers, or could be simply caused by the
ectopic expression of the constructs. These proteins were not
studied further at this point. Amongst the three best hits, we
focused on Bin1 because it is ubiquitously expressed, unlike
Amphiphysin, which is brain-enriched46,47. Bin2 is a known
binding partner of Endophilin that is mainly expressed in
leukocytes and that heterodimerizes with Bin1 but not
Amphiphysin48,49. Bin1 has several splice variants, including
brain-specific long isoforms 1–7 (also known as Amphiphysin-II)
that contain AP2-binding and Clathrin-binding motifs and
function in CME50. The two ubiquitously-expressed, short
isoforms 9 and 10, however, resemble Endophilin in that they
have a N-BAR domain, a short linker and SH3 domain and
colocalize poorly with either AP2 or Clathrin (immunostaining,
Suppl. Fig. 6a). Endogenous Bin1 localized onto the majority of
FEME carriers produced upon either β1AR activation or Cdk5
and GSK3β inhibition (Fig. 7c). Like Endophilin6, Bin1 binds to
Lpd (Suppl. Fig. 6d) and relies on both CIP4 and Lpd for its
recruitment into the transient clusters priming the leading edges
of resting cells (Suppl. Fig. 6b, c). In cells depleted for Bin1
(Amphiphysin and Bin1 double knock-down, Amph+Bin1 DKD,
was performed to avoid potential compensation), CIP4, Lpd, and
Endophilin were recruited as in control cells (Suppl. Fig. 6b, c)
and β1AR uptake was not affected6. This suggested that Bin1
could be mediating the uptake of different cargoes other than
β1AR and/or that it could have a later role, postbudding. In
absence of data supporting or rebutting the first hypothesis, we
focused on the potential link with Dynein that we reported above.
Pull-down experiments revealed that the SH3 domain of Bin1
and not that of Endophilin isolated endogenous Dynein (Fig. 7d).
As it was unlikely for Bin1 to bind directly to the motor domain,
we tested Dynactin subunits that were identified by mass
spectrometry in previous pull-downs6. However, neither Bin1
nor Endophilin bound to the p150glued or p27 subunits (Suppl.
Fig. 6e). Stimulation of FEME by serum addition increased
Dynein binding to Bin1 and recruitment onto FEME carriers
(Fig. 7d, e and Suppl. Fig. 6f). Acute inhibition of Cdk5 and
GSK3β increased the recruitment further, confirming that these
kinases negatively regulate Dynein loading onto FEME carriers
(Figs. 6c, d and 7e and Suppl. Fig. 6f). Remaining EPAs produced
in cells depleted for Bin1 showed reduced colocalization with of
Dynein (Fig. 7e), and often clustered at the cell periphery.
Collectively, we showed that Bin1 recruits Dynein onto FEME
carriers, under the control of Cdk5 and GSK3β. All our data taken
together established these kinases as master regulators of FEME,
antagonizing the process at several levels including cargo sorting,
Dynamin and Dynein recruitment (Fig. 7f).
Discussion
Cdk5 and GSK3β play important roles in regulating endocytosis.
The best understood mechanism involves the phosphorylation of
Dynamin-1 at Ser778 by Cdk5, followed by that of Ser774 by
GSK3β9,20. Phosphorylation of Ser778 hampers the recruitment
of Dynamin-1 by binding partners such as Endophilin22, whereas
phosphorylation of Ser774 inhibits Dynamin-1 activity8. These
phosphorylations dampen CME but activate activity-dependent
bulk endocytosis (ADBE), suggesting they might mediate the
crosstalk between CME, FEME, and ADBE8,9. Several other
endocytic proteins including Amphiphysin, are targets of these
kinases in synapses7,51. Upon axon depolarization, the phos-
phatase Calcineurin is activated by the sudden Ca2+ rise, med-
iating the acute dephosphorylation of Amphiphysin and
Dynamin. Prompt removal of the inhibitory phosphorylations
then swiftly activates compensatory endocytosis52,53.
Here, we found that, similarly to their function of regulating
endocytosis in synapses, Cdk5 and GSK3β suppress FEME
(Figs. 1–4). Some of the mechanisms are shared, as for example
the regulation of Dynamin-1, but others appear different in the
case of FEME. Indeed, the kinases also regulate cargo protein
sorting by Endophilin, as well as Dynein recruitment by Bin1
(Figs. 5–7). We furthermore established that Endophilin binds to
PlexinA1 adaptor CRMP4 via a Proline-rich motif adjacent to the
sites phosphorylated by Cdk5 and GSK3β, thereby placing the
sorting of the receptor into FEME carriers under negative reg-
ulation by these kinases (Fig. 5). Our data also establish that, in
mouse hippocampal neurons, axon extension and branching are
regulated by the CRMP4-Endophilin interaction. These processes
establish most of the synaptic connectivity in the central nervous
system of vertebrates32,54. When CRMP4 was unlinked from the
FEME pathway upon expression of the CRMP4-R525E mutant
that cannot bind to Endophilin, axons were shorter and showed a
defect in branching (Fig. 5). This was due to the reduced ability of
these neurons to form functional AGCs or a higher tendency to
collapse in response to low levels of endogenous Semaphorin 3A
secreted into the media55. Although we cannot rule out a direct
effect of the overexpression of the CRMP4 mutants, such
hypersensitivity was likely induced by an increased level of
endogenous Plexin A1 remaining at the cell surface upon
blocking CRMP4 from being sorted into the FEME pathway.
Conversely, overexpression of the CRMP4-S522A mutant, which
blocks Cdk5-mediated inhibition of the CRMP4-Endophilin
interaction induced the opposite phenotype: axon branching
was normal and AGCs did not collapse, even upon ectopic
addition of Semaphorin 3A (Fig. 5). This suggested that Plexin A1
was more actively internalised in these neurons, as we measured
in HUVEC upon Cdk5 inhibition. Even though GSK3β does not
appear to regulate the binding of CRMP4 to Endophilin, it con-
trols other steps of FEME as well as axon branching and elon-
gation through other functions of the CRMP complex19,56. Thus,
our data shows that the dual regulation of FEME by Cdk5 and
GSK3β has physiological importance in neurons, beyond the
simple control of endocytosis.
We also found the uptake of Slit1 and its receptor ROBO1 to be
under control of Cdk5 and GSK3β for their recruitment into
FEME carriers (Suppl. Fig. 4). However, we do not know yet
whether this regulatory mechanism is more generally used in the
uptake of other FEME cargo as well. Several known FEME cargo
proteins, including β1-Adrenergic receptor and CIN85 (the
adaptor for EGFR), also contain a Serine–Proline motif (con-
sensus site for Cdk5) within or adjacent to their Endophilin
binding sites, suggesting that they could also be regulated by the
mechanism described herein.
We have also shown that Cdk5 and GSK3β block the recruit-
ment of Dynein onto FEME carriers (Fig. 6). We established that
Bin1 engages the microtubule motor, and is another cytosolic
marker of FEME carriers (Fig. 7). Thus, like Endophilin, Bin1
functions in FEME in addition to its role in CME. Ubiquitously
expressed short isoforms 9 and 10 colocalized poorly with CME
markers, in agreement with their lack of binding motifs to AP2
and Clathrin50. We cannot rule out that Bin1 has additional
functions other than recruiting Dynein, nor can we exclude that
another protein recruits the motor protein onto EPAs either in
the absence of, or in parallel to Bin1. How Cdk5 and GSK3β
control the loading of FEME carriers onto Dynein is not known at
this point, as we failed to show an interaction between Bin1 and
the obvious candidates p150glued and p27. However, multiple
Dynein adaptors such as Ndel1L, Lis1, or BICD, have been
reported to be phosphorylated by either kinases37,57,58 and could
be the link to Bin1. Additional layers of regulation are certainly at
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play as both Cdk5 and GSK3β regulate Dynein processivity, in
addition to cargo loading37,38,59,60.
There may be additional levels of regulation by Cdk5 and
GSK3β, either by regulation of other key steps of FEME or, more
indirectly, by modulating the activity of other kinases. GSK3β
inactivates both FAK1 (upon phosphorylation of Ser72261) and
mTOR signaling (upon phosphorylation of TSC2 on Ser1341,
Ser1337 and Ser134562). Both FAK1 and mTORC1/2 were found
to be FEME activators in our screen, as their acute inhibition
blocked FEME (Fig. 1). This could imply that Cdk5 and GSK3β
are master regulators of FEME acting both on the machinery as
well as on other kinases potentially regulating the pathway. The
finding that Endophilin binds to GSK3β suggest that local reg-
ulation is required to control FEME. The binding to GSK3β but
not α stems from the presence of several PRMs in the former that
are not conserved in GSK3α. Even though GSK3α and β share
high sequence similarity, no clear role for GSK3α has been
assigned in endocytosis, perhaps owing to a defect in local
recruitment, due to its lack of binding to Endophilin.
It is now clear that various cell types have different levels of
FEME activity. There are strong differences in the maximum
number in FEME carriers produced upon growth factor addition:
a factor of 7 between the weakest and the strongest tested
(HEK293 and HUVEC, respectively, Suppl. Fig. 1). We also found
that some cell types displayed spontaneous FEME (i.e., not
induced experimentally), detected here in RPE1, hDFA and
HUVEC cells. This is likely due to the high levels of growth
factors in their culture in media: primary cells are routinely
grown in medium supplemented with high doses of EGF, FGF,
VEGF and/or IGF-1, which all trigger FEME5. Both Cdk5 and
GSK3β control the level of FEME in a particular cell type, but
only the sum of the activities of the two kinases (and perhaps that
of other priming kinases that are yet to be identified) can predict
the propensity of a cell type to be FEME active.
The signal for relieving the inhibition imposed by Cdk5 and
GSK3β is not yet understood. The promptness of FEME activa-
tion upon stimulation of cargo receptors suggests that phospha-
tases likely erase inhibitory phosphorylations. However, which
one could be acting downstream of receptors as diverse as Gαs or
Gαi-coupled GPCRs, RTKs, cytokine or cell guidance receptors
(all the FEME cargoes known to date), is not obvious. In addition,
kinases other than Cdk5 are likely priming GSK3β phosphor-
ylation during FEME. Some Endophilin functions are regulated
by LRKK2, DYRK1A and Src63–65, but inhibitors toward these
kinases did not affect spontaneous FEME in resting RPE1 cells. It
is possible that dual inhibition together with GSK3β is required or
that they regulate other FEME cargoes or processes. Thus, while a
complex regulatory mechanism is likely to emerge from future
work, the current study revealed the key role of Cdk5 and GSK3β
in inhibiting FEME in absence of receptor activation.
Methods
Cell culture. Human normal diploid hTERT-RPE-1 (ATCC CRL-4000, called
RPE1 in this study) cells were cultured in DMEM:F12 HAM 1:1 v/v (Sigma
D6421), 0.25% Sodium bicarbonate w/v (Sigma), 1 mM GlutaMAX-I (Thermo
Fisher), 1× antibiotic–antimycotic (Thermo Fisher), and 10% fetal bovine serum
(FBS; Thermo Fisher). Human Primary Dermal Fibroblasts (ATCC PCS-201-012,
called hDFA in this study) were cultured in DMEM:F12 HAM 1:1 v/v (Sigma
D6421), 7.5 mM GlutaMAX-I (Thermo Fisher), 1× antibiotic–antimycotic
(Thermo Fisher), 2% FBS (Thermo Fisher), 0.8 μM Insulin (MP Biomedicals
0219390025), 10 ng/mL Basic Fibroblast Growth Factor (bFGF, LifeTech
PHG0024), 50 μg/mL Hydrocortisone and 1 μg/mL ascorbic acid. Human umbilical
vein endothelial cells, HUVEC (ATCC PCS-100-010 or a kind gift from Tom
Nightingale (Queen Mary University)) were grown in endothelial cell growth
medium containing 0.02 mL/mL Fetal Calf Serum, 5 ng/mL recombinant human
Epidermal Growth Factor (EGF), 10 ng/mL Basic Fibroblast Growth Factor
(bFGF), 20 ng/mL Insulin-like Growth Factor (IGF-1), 0.5 ng/mL recombinant
human Vascular Endothelial Growth Factor 165 (VEGF-165), 1 μg/mL ascorbic
acid, 22.5 μg/mL Heparin and 0.2 μg/mL Hydrocortisone (Promocell, C-22011).
Human HeLa cells (ATCC CCL-2), human embryonic kidney HEK293 (ATCC
CRL-1573, called HEK in this study) and African green monkey BSC-1 (ECACC
85011422), were cultured in DMEM (Sigma D6546) supplemented with 10% FBS,
1 mM GlutaMAX-I (Thermo Fisher), 5% 1× antibiotic–antimycotic (Thermo
Fisher). Mouse hippocampal neurons were initially seeded in neuronal attachment
media (Minimum Essential Medium Eagle’s with Earl’s BSS (Sigma), 10% (w/v)
FBS (Thermo Fisher), 1 mM sodium pyruvate (Sigma), 20% (w/v) glucose (Sigma),
2 mM glutamax (Thermo Fisher), antibiotic–antimycotic (Sigma)) and maintained
at 37 °C, 5% CO2 for 6 h after which the media was exchanged to neuronal
maintenance media (Neurobasal (Thermo Fisher), 2% (w/v) B27 (Thermo Fisher),
2 mM GlutaMAX-I (Thermo Fisher), antibiotic-antimycotic (Sigma)). All the cells
were maintained at 37 °C, 5% CO2. Cells were regularly tested for mycoplasma
contamination.
Animals. All procedures for the care and treatment of animals were in accordance
with the Animals (Scientific procedures) Act 1986, and had full Home Office
ethical approval. Animals were maintained under controlled conditions (tem-
perature 20 ± 2 °C; 12 h light-dark cycle), were housed in conventional cages and
had not been subject to previous procedures. Food and water were provided ad
libitum. Wild-type C57BL6J mice were generated as a result of wild-type breeding;
embryos of either sex were used for generating primary neuronal cultures.
Neuronal culture and analysis. Cultures of hippocampal neurons were prepared
from wild-type C57BL6J mouse embryos (E16), using the following protocol66:
mouse hippocampi were dissected from embryos brains in ice-cold HBSS (Gibco)
supplemented withy 10mM HEPES. Dissected hippocampi were incubated in the
presence of 0.25% trypsin and 5 units/mL DNAse for 15min at 37 °C, washed twice
with HBSS with HEPES, and triturated to a single cell suspension in attachment
media (MEM, (Gibco) containing 10% horse serum, 10mM sodium pyruvate and
0.6% glucose) using a fire-polished glass pasteur pipette. Dissociated neurons were
electroporated with CRMP4-EGFP constructs using Amaxa nucleofector (Lonza).
This allowed tracing individual neurons/axons. Two hundred nanogram of DNA
construct were used to electroporate 5 × 104 cells per condition. The neurons were
then transferred into 96-well plates previously coated with poly-L-lysine (0.05 mg/
mL, Sigma) in PBS overnight at 37 °C, 5% CO2, followed by a second coating of
Laminin (0.01 mg/mL) for 2 h at 37 °C, 5% CO2. Approximately 5 × 104 transfected
hippocampal neurons were seeded per well with an additional 9 × 103 non-
transfected neurons seeded on top of the transfected neurons to support survival.
Cells were initially allowed to attach in neuronal attachment media (described above)
and grown at 37 °C, 5% CO2 for 6 h, followed by media exchange with neuronal
maintenance media. At day 4, cells were fixed and stained for F-actin (Phalloidin-
555) and DNA (DAPI) and imaged using an imageXpress microscope (Molecular
Devices). Axon length was determined by measuring the longest neurite using
imageJ. In case an axon was branched the whole axon length was measured,
including the branches. Axon branches were considered both arboreal (terminal)
branches and also the interstitial (collateral) branches when they were located over or
under 100 μm from the axon growth cones, respectively. Axon growth cone collapse
was induced upon incubation of neuronal cultures with 5 nM recombinant sema-
phorin 3A for 20min at 37 °C, 5% CO2, before fixation with pre-warmed 4% PFA for
20min at 37 °C and then stained. Growth cones were classified as collapsed if the
actin lamellipodia/filopodia was shrunk or absent.
Small compound inhibitors and ligands. The following small compound inhi-
bitors (amongst the best-reported inhibitors for each kinase11,12) were used: AZ191
(called DYRKi in this study Cayman 17693), AZD0530 aka Sacratinib (called SRCi
in this study, Cayman 11497), BI-D1870 (called p90RSKi in this study, Cayman
15264), BIO-6-bromoindirubin-3′-oxime, aka BIO (called GSK3i2 in this study,
(Sigma B1686), BI 2536 (called PLKi in this study, Selleckchem S1109), CDK1/2
inhibitor III (called Cdk1/2i in this study, Merck 217714), CHIR-99041 (called
GSK3i1 in this study, Cayman 13122), Ciliobrevin D (called Ciliobrevin in this
study, Calbiochem 250401), CX-4945 (called CK2i in this study, Cayman 16779),
Dinaciclib (called Cdk1/2/5/9i in this study, MedChemExpress Hy-10492),
Dobutamine (Sigma D0676), D4476 (called CK1i in this study, BioVision 1770),
GDC-0879 (called BRAFi in this study, Tocris 4453), GDC-0941 (called PI3Ki in
this study, Symansis SYG0941), Genistein (called Y-kinases in this study, Calbio-
chem 245834), GNE-7915 (called LRRK2i in this study, MedChemExpress Hy-
10328), GSK2334470 (called PDKi in this study, Cayman 18095), GW 5074 (called
CRAFi in this study, Santa Crux sc-200639), Harmine hydrochloride (called
DYRKi in this study, Santa Crux sc2595136), JNK-IN-8 (called JNKi in this study
MedChemExpress Hy-13319), KT 5720 (called PKAi in this study Cayman
10011011), MK2206 (called AKTi in this study, LKT Laboratories M4000), MLR
1023 (called LYNa in this study, Tocris 4582), PD0325901 (called MEKi in this
study, Tocris 4192), PD0332991 aka Palbociclib (called Cdk4/6i in this study,
Sigma PZ0199), PF-4708671 (called p70S6Ki in this study, MedChemExpress Hy-
15773), PF-4800567 (called CK1Ei in this study, Cayman 19171), PHA-793887
(called Cdk2/5/7i in this study, ApexBio A5459), PND-1186 (called FAKi in this
study, MedChemExpress Hy-13917), Purvalanol A (called Cdk1/2/4i in this study,
Santa Cruz sc-224244), P505-15 (called SYKi in this study, Adooq Bioscence
A11952), Roscovitine (called Cdk1/2/5i in this study, Santa Cruz sc-24002), RO-
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3306 (called Cdk1i in this study, Cayman 15149), SCH772984 (called ERKi in this
study, Sellekchem S7101), Staurosporine (called broad kinases in this study, Alo-
mone Labs AM-2282), STO609 (called CaMKK1/2i in this study, Cayman 15325),
TAK-632 (called panRAFi in this study, Selleckchem S7291), Torin 1 (called
mTORC1i in this study, Tocris 4247), VX-745 (called p38i in this study, Med-
ChemExpress Hy-10328) and ZM 447439 (called AurA/AurBi in this study, Cay-
man 13601). The following ligands were used: human Semaphorin 3A extracellular
region 6 (6×N-terminal His-tag, R&D 1250-S3) and human Slit1 (6×C-terminal
His-tag, R&D 6514-SL-050).
Gene cloning and mutagenesis. Full length and truncated genes (all human,
unless specified) were amplified and cloned into pDONR201 (Invitrogen) and
transferred into pEGFP, pTagRFP-T (called RFP in this study), pMyc, or pGEX-
6P2 vectors converted into the Gateway system (pDEST vectors made from a pCI
backbone), as appropriate: Endophilin-A2 (SH3GL1, IMAGE 3458016) full length
and SH3 domain (aa 311-end); Endophilin-A1 (SH3GL2 iso1, FLJ 92732) full
length and SH3 domain (aa 295-end); Endophilin-A3 (SH3GL3 iso 1, IMAGE
5197246) full length and SH3 domain (aa 291-end); Bin1, also known as
Amphiphysin-II (BIN1 iso9, cloned from human brain cDNA library) full length
and SH3 domain (aa 366-end); full length CRMP2 (DPYSL2, DNASU
HsCD00513405), full length CRMP3 (DPYSL4, NM_006426 Origene), full length
mouse CRMP4 (DPYSL3, Origene 1197294), full length CRMP5 (DPYSL5,
amplified from human brain cDNA library, Novagen), Ephrin receptor A1 cyto-
plasmic tail (aa 568-976) (EPHA1, DNASU HsCD00516390), Ephrin receptor A6
cytoplasmic tail (aa 572-1036) (EPHA6, DNASU HsCD00350501), Ephrin receptor
B1 cytoplasmic tail (aa 259-346) (EPHB1, DNASU HsCD00038738), Ephrin
receptor B4 cytoplasmic tail (aa 561-987) (EPHB4, DNASU HsCD00021508),
Ephrin receptor B6 cytoplasmic tail (aa 616-1021) (EPHB6, DNASU
HsCD00505529), Semaphorin 4D cytoplasmic tail (aa 756–862) (SEMA4D,
amplified from human brain cDNA library, Novagen), Semaphorin 4F cytoplasmic
tail (aa 681–770) (SEMA4F, DNASU HsCD00041427), Semaphorin 6A cyto-
plasmic tail (aa 671–1030) (SEMA6A, Sino Biologica HG11189-M), Semaphorin 6B
cytoplasmic tail (aa 616–1021) (SEMA6B, amplified from human brain cDNA
library, Novagen); Semaphorin 6D cytoplasmic tail (aa 684–1073) (SEMA6D,
DNASU HsCD00516397); Plexin B1 cytoplasmic tail (aa 1512–2135) (PLXNB1,
Addgene 25352), mouse Roundabout homolog 1 cytoplasmic tail (aa 880–1612)
(ROBO1, DNASU HsCD00295416); Roundabout homolog 3 cytoplasmic tail (aa
912–1386) (ROBO3, DNASU HsCD00302878) and Netrin receptor UNC5B cyto-
plasmic tail (aa 398–945) (UNC5B, DNASU HsCD294959), EGFP-p27 (Addgene
#15192); EGFP-p150Glued (Addgene #36154). Bovine Dynamin 1-EGFP and rat
GST-Bin1 SH3 domain were kind gifts from Harvey McMahon (MRC Cambridge),
EGFP-p50 dynamitin (full length DCTN2) was a kind gift from Serge Benichou
(Institut Cochin, Paris) and EGFP-TPR (mouse KLC2 TPR domains aa 155–599)
was a kind gift from Michael Way (Crick Institute, London). EGFP-tagged human
full-length BAR domain proteins library was described before6. Point mutations
P502A, S522A, S522D, R525E, and P526A were introduced in full length mouse
CRMP4 and S774A and S778A were introduced in full length rat Dynamin-1 by
site-directed mutagenesis and verified by sequencing. The list of primers used in
this study is provided in Supplementary Table 1.
Gene transfection. For fixed cell colocalization experiments, cells seeded on 13
mm coverslips (placed in 24-well plates) were transfected using Lipofectamine 2000
(Thermo Fisher) or Nanofectin (PAA) and 10–500 ng DNA depending on the
plasmids and the experiments (low or high overexpression). The levels of each
plasmid were titrated down to low levels allowing good detection but limiting side
effects of overexpression. Cells seeded onto live-cell imaging 35 mm glass bottom
dishes (MatTek) were transfected using Lipofectamine 2000 (Thermo Fisher) and
50–250 ng DNA. For pull-down experiments, co-immunoprecipitation and EGFP-
trap immunopurifications, HEK293 cells seeded in 6-well plates or 100 mm dishes
were transfected using GeneJuice (Merck) and 1–3 μg DNA. Cells were incubated
16–24 h to express the constructs and were either imaged live, fixed (4% pre-
warmed paraformaldehyde, 20 min at 37 °C) or processed to prepare cell extracts.
siRNA suppression of gene expression. The following siRNA oligos (all Stealth,
Thermo Fisher) were used: Endophilin A1, A2, and A3 triple knock-down (Endo
TKD) was achieved by combining oligos against Endophilin A1 (Thermo
HSS109709; 2 oligos against human SH3GL2), Endophilin A2 (Thermo
HSS109707; 2 oligos against SH3GL1) and Endophilin A3 (Thermo HSS109712; 2
oligos against human SH3GL3); AP2 (Thermo HSS101955 (2 oligos against human
AP2M1); CDK5 (Thermo HSS101729; 2 oligos against human CDK5); GSK3α/β
double knock-down (DKD) was achieved by combining oligos against GSK3α
(Thermo HSS104518; 2 oligos against human GSK3A) and GSK3β (Thermo
HSS104522; 2 oligos against human GSK3B); CDK5+GSK3α/β triple knock-down
(TKD) was achieved by combining aforementioned oligos against CDK5 and
GSK3α/β; AMPH+Bin1 double knock-down (DKD) was achieved by combining
oligos against Amphiphysin-1 (Thermo HSS100465; 2 oligos against human
AMPH) and Bin1 (Thermo HSS100468; 2 oligos against human BIN1); FBP17
+CIP4+TOCA-1 triple knock-down (TKD) was achieved by combining oligos
against FBP17 (Thermo HSS118093; 2 oligos against human FNBP1),
CIP4 (Thermo HSS113814; 2 oligos against human TRIP10) and (Thermo
HSS123422; 2 oligos against human FNBP1L); and Lamellipodin (Dharmacon ON-
TARGETplus SMARTpool mix of J-031919-08, J-031919-07, J-031919-06, and J-
031919-05 targeting human RAPH1). Control siRNA used were Invitrogen Stealth
control (scrambled) oligo 138782. Cells seeded on 13 mm coverslips placed in 24-
well plates were transfected twice (on day 1 and 2) with Oligofectamine or RNAi
MAX (Thermo Fisher) complexed with 20 pmol of each indicated siRNA and
analyzed 3–4 days after the first transfection. RNAi knock-down efficiency was
verified by western-blotting or immunofluorescence counter-staining. The use of
validated pools of siRNA targeting the same genes increased the knock-down
efficiency and specificity.
Antibodies. The following primary antibodies were used for immunostaining or
immunoblotting: anti-EGFP ab290 (rabbit polyclonal, Abcam290) used at 0.5 μg/mL
(1:8000 dilution), anti-EGFP clones 7.1 and 13.1 (mouse monoclonal, Roche
11814460001) used at 0.5 μg/mL (1:1000 dilution), anti-Endophilin A2 clone H-60
(rabbit polyclonal, Santa Cruz 25495)), used at 1 μg/mL (1:100 dilution), anti-
Endophilin A2 clone A-11 (mouse polyclonal, Santa Cruz 365704) used at 1 μg/mL
(1:200 dilution), anti-β1 adrenergic receptor (rabbit polyclonal, Abcam ab3442) used
at 1μg/mL (1:1000 dilution), anti-CRMP4 (rabbit polyclonal, Milipore 5454) used at 2
μg/mL (1:100 dilution), anti-Dynein clone 74.1 (mouse monoclonal, eBioscience 14-
9772-80) used at 2 μg/mL (1:100 dilution), anti-Plexin A1 (rabbit polyclonal recog-
nizing the ectodomain of PlexinA1, Abcam Ab32960) used at 1 μg/mL (1:100 dilu-
tion), anti-ROBO1 (sheep polyclonal, AF7118 R&D Systems) used at 1 μg/mL (1:500
dilution), anti-LAMP-1 (mouse monoclonal clone H4A3-c, Developmental Studies
Hybridoma Bank) used at 1:5000 dilution, anti-phosphorylated Ser9 GSK3β clone
D85E12 (rabbit monoclonal, Cell Signaling Technology 5558) used at 1 μg/mL (1:400
dilution), anti-GSKα/β D75D3 (rabbit polyclonal, Cell Signaling Technology 5676)
used at 1 μg/mL (1:400 dilution), anti-Dynamin 1 clone 41 (mouse monoclonal, BD
Pharmigen 610245) used at 1 μg/mL (1:250 dilution), anti-Bin1 (rabbit polyclonal,
GeneTex GTX103259) used at 2 μg/mL (1:500 dilution), anti-Lamellipodin (rabbit
polyclonal, Atlas Antibodies HPA020027) used at 2 μg/mL (1:50 dilution), anti-CIP4,
(mousemonoclonal clone 21, Santa Cruz sc-135868) used at 1 μg/mL (1:200 dilution),
anti-α Tubulin clone TUB2.1 (mousemonoclonal, Abcam ab11308) used at 0.5 μg/mL
(1:2000 dilution), and anti-His tag clone D3I10 (rabbit polyclonal, Cell Signaling
Technology 12698) used at 1 μg/mL (1:400 dilution). The following secondary anti-
bodies were used for microscopy: Alexa Fluor 488 goat anti-mouse IgG (Thermo
Scientific A-11001), Alexa Fluor 555 goat anti-mouse IgG, (Thermo Scientific A-
21422), Alexa Fluor 488 goat anti-rabbit IgG, (Thermo Scientific A-11008), Alexa
Fluor 555 goat anti-rabbit IgG, (Thermo Scientific A-21428), Alexa Fluor 388 donkey
anti-Sheep IgG (Thermo Scientific A-11015), Alexa Fluor 555 donkey anti-mouse IgG
(Thermo Scientific A-31570), and for immunoblot; goat anti-mouse IgG-HRP con-
jugated (Bio-Rad 1706516) and goat anti-rabbit IgG-HRP conjugated (Bio-Rad
1706519). Actin was stained using Phalloidin-Alexa647 (Cell Signaling Technology
8940) and DNA using DRAQ5 (BioStatus DR50200).
Cell stimulation and cargo uptake. Cells were kept at 37 °C and 5% CO2 during
the whole assay (apart during medium exchanges) and never serum-starved or pre-
incubated at 4 °C. Resting conditions correspond to cells being cultured in 10%
serum media and directly fixed (4% pre-warmed paraformaldehyde) for 20 min at
37 °C. Kinase inhibition was achieved by incubating cells grow in full medium (10%
serum) with the indicated small compound inhibitors at the indicated concentra-
tions and for the indicated times at 37 °C before being washed once with 37 °C pre-
warmed PBS and fixed (4% pre-warmed paraformaldehyde) for 20 min at 37 °C.
Serum stimulation was achieved by adding 37 °C pre-warmed 10% serum on
complete medium (20% serum final) for the indicated times. β1 adrenergic receptor
stimulation (which activates FEME) was performed by incubating cells at 37 °C for
4 or 30 min with pre-warmed medium containing 10μM dobutamine. Plexin A1
uptake was performed by incubating cells at 37 °C for 5–20 min with pre-warmed
medium containing 20 nM Semaphorin 3A and 10 μg/mL anti-PlexinA1 antibodies
(recognizing the ectodomain of PlexinA1). ROBO1 stimulation was performed by
incubating cells at 37 °C for 10 min with pre-warmed medium containing 2 nM
Slit1-(His)6. In some experiments, cells were pre-incubated at 37 °C for the indi-
cated times with small compound inhibitors before stimulation with dobutamine,
Semaphorin 3A or Slit1 (in constant inhibitor concentration). After the incubation
periods at 37 °C, cells stimulated as described above were quickly washed once with
37 °C pre-warmed PBS to removed unbound ligands and fixed with pre-warmed
4% PFA for 20 min at 37 °C (to preserve Endophilin staining and FEME carriers
morphology). In some experiments, unbound and cell suface anti-PlexinA1 anti-
bodies were removed by one quick wash in ice-cold PBS++ (containing 1 mM
CaCl2 and 1 mMMgCl2) followed by two 5min incubations on ice in acid stripping
buffer (150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 0.2 M acetic acid
adjusted to pH 2.5), followed by two washes on ice in PBS++ to normalize pH back
to 7. Fixed cells were then washed three times with PBS and one time with PBS
supplemented with 50 mM NH4Cl to quench free PFA. Cells were then permea-
bilized (0.05% saponin), immunostained and imaged as described below.
Immunostaining and confocal fluorescence microscopy. Cells were fixed with
4% PFA at 37 °C for 20 min, washed three times with PBS and one time with PBS
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with 50 mM NH4Cl to quench free PFA. Cells were then permeabilized for 5 min
with PBS with 0.05% saponin and immunostained with primary and secondary
antibodies in PBS with 0.05% saponin (Sigma) and 5% heat inactivated Horse
Serum. Cover slips 0.13–0.16 mm (Academy) were mounted on slides (Thermo
scientific) using immunomount DAPCO (GeneTex) and imaged using a laser
scanning confocal microscope (TCS Sp5 AOBS; Leica) equipped with a 63×
objective. For Alexa488, the illumination was at 488 nm and emission collected
between 498 and 548 nm; for Alexa555 the laser illumination was at 543 nm and
emission collected between 555 and 620 nm; for Alexa647 and DRAQ5, the laser
illumination was at 633 nm and emission collected between 660 and 746 nm.
Correlation between total Cdk5 or GSK3β cellular levels and number of EPAs was
determined from single cell measurements on the same cells (i.e., matching Cdk5
or GSK3β levels with the number of EPAs in each individual cell measured). The
percentages of endophilin spots located at the leading edge of cells or FEME
carriers (EPAs) positive for endogenous GSK3β, Dynamin-1, CRMP4, Dynein, or
Bin1 were determined by line scans using Volocity 6.0. Colocalization of over-
expressed Endophilin-A2-RFP and EGFP-tagged CRMP4 constructs were deter-
mined by Manders’ overlap using Volocity 6.0. The percentages of FEME carriers
(EPAs) positive for BAR domain tagged with EGFP were determined by line scans
using Volocity 6.0. The percentages of Bin1 spots positive for endogenous Endo-
philin, Lamellipodin, CIP4, or Dynein were determined by line scans using
Volocity 6.0. Levels of endogenous β1AR, PlexinA1, or recombinant Slit1 inter-
nalized into FEME carriers were measured by using Volocity 6.0. Micrographs were
cropped using ImageJ 1.51s (NIH) or Photoshop CS5 (Adobe).
Live-cell confocal fluorescent microscopy. Just before live-cell imaging, the
medium of cells grown on MatTek dishes was changed to α-MEM without phenol
red, supplemented with 20 mM HEPES, pH 7.4 and 5% FBS and placed into a
temperature controlled chamber on the microscope stage with 95% air: 5% CO2
and 100% humidity. Live-cell imaging data were acquired using a fully motorized
inverted microscope (Eclipse TE-2000, Nikon) equipped with a CSU-X1 spinning
disk confocal head (UltraVIEW VoX, Perkin-Elmer) using a 60× lens (Plan
Apochromat VC, 1.4 NA, Nikon) under control of Volocity 6.0 (Improvision,
Perkin-Elmer). 14-bit digital images were obtained with a cooled EMCCD camera
(9100-02, Hamamatsu, Japan). Four 50 mW solid-state lasers (405, 488, 561, and
647 nm; Crystal Laser and Melles Griots) coupled to individual acoustic-optical
tunable filter (AOTF) were used as light source to excite EGFP and TagRFP-T.
Rapid two-colour time-lapses were acquired at 500 ms to 2 s intervals, using a dual
(525/50; 640/120, Chroma) emission filter, respectively. The power of the lasers
supported excitation times of 50 ms in each wavelength and the AOTFs allowed
minimum delay (~1 ms) between two colors (e.g., delay between green-red for each
timepoint), which was an important factor to assess the colocalization between
markers.
Protein purification and pull down experiments. GST or GST-tagged SH3
domains were expressed in BL21 (DE3) E. coli (New England Biolabs). Cells were
lysed by sonication in presence of lysozyme (Affymetrix), protease inhibitor
(Thermo Scientific), and DNAse powder (Sigma-Aldrich), spun at 5,000×g for 1 h
at 4 °C. The supernatants containing the GST or GST-SH3 domains (soluble
fraction) were concentrated (to ~60 mg/mL) using a Centricon Plus 70-1000
NMWL (Centricon) for 1 h at 4 °C and then incubated rotating with GST-
sepharose beads (PierceTM glutathione superflow agarose) overnight at 4 °C. The
beads were washed ten times with ice-cold PBS and kept in PBS and sodium azide
0.02% solution at 4 °C and used in pull-down assays. Cell lysates—non-transfected
or overexpressing EGFP-tagged proteins—were prepared in lysis buffer (20 mM
HEPES, 1 mM EDTA, 0.2% Triton X-100 and protease inhibitor cocktail (Roche))
briefly sonicated (three times 5 s pulses with 30 s rest, 10 μm amplitude) and spun
at 20,000 × g for 10 min at 4 °C. Cell lysates were incubated with bead-bound
proteins (amounts were calibrated by gel electrophoresis followed by Coomasie to
equivalent amounts) overnight at 4 °C and then centrifuged at 7500 × g and washed
three times with lysis buffer. The remaining bead pellet was boiled in SDS sample
buffer and run on SDS-PAGE. Input lanes correspond to 5% of cell extract. The
final pellets (bound fractions), supernatants (unbound fractions) and original
extracts (input fractions) were boiled in sample buffer and ran on SDS-PAGE. The
proteins were transferred onto PVDF membrane and immunoblotted using anti-
EGFP antibodies or antibodies against endogenous proteins, as indicated, followed
by HRP-coupled secondary antibodies (BioRad). Blots were developed with the
ECL kit (Thermo Fischer Scientific or Merck Millipore) and x-ray film and
quantified using ImageLab 6.1 (Bio-Rad).
Co-immunoprecipitations. HEK293 cells were co-transfected with equal amounts
(1–3 μg) of Myc-tagged and EGFP-tagged BAR domain constructs. After 16–24 h
expression, cells were quickly washed with cold PBS, lysed in ice-cold lysis buffer
(10mM Tris HCL pH 7.5, 150mMNaCl, 0.5 mM EDTA, 0.5% NP40 and a protease
and phosphatase inhibitor cocktail (Thermo Scientific)) and spun at 14,000 × g for
10min at 4 °C. Cell lysates were incubated with GFP-TRAP_A or M (Chromotek)
bead slurry for 1–16 h at 4 °C. The beads were washed three times (10mM Tris
HCL pH 7.5, 150mM NaCl, 0.5 mM EDTA). The final pellets and unbound frac-
tions were boiled in SDS sample buffer and ran on SDS-PAGE (input lanes
correspond to 1–10% of cell extracts). The proteins were transferred onto PVDF
membrane and immunoblotted using anti-Myc, anti-EGFP, antibodies, or anti-
bodies against endogenous proteins, as indicated, followed by HRP-coupled sec-
ondary antibodies (BioRad). Blots were developed with the ECL kit (Thermo Fischer
Scientific or Merck Millipore) and x-ray films. Uncropped and unprocessed Wes-
tern blots are shown in the Source Data file.
FEME carrier isolation. RPE1 cells grown on 15 cm dishes were stimulated with
extra 10% FBS (20% final) for 10min at 37 °C, quickly rinsed with ice-cold PBS+++
(PBS with 1 mM Ca2+, protease and phosphatase inhhibitors), collected using a cell
scraper and pelleted (400 × g, 5 min, 4 °C). Cell pellets were loosened in 1 mL of ice-
cold homogenization buffer A (HBA) (3mM Imidazol pH 7.4, 1 mM EDTA, and
0.03mM cycloheximide plus protease and phosphatase inhibitor cocktail), spun
(1300 × g, 10 min, 4 °C), resuspendend into one volume of HBA and incubated for
20 min on ice. One volume of homogenization buffer B (HBB; HBA containing 500
mM sucrose) was added and cells were mechanically lysed through 25G needles,
avoiding nuclei disruption. Homogenates were diluted into HBB (one part homo-
genetate and 0.7 part HBB) and post-nuclear supernatants (PNS) were collected
after spinning (two time, 2000 × g, 10 min, 4 °C). Sucrose concentration of the PNS
was adjusted to 40.6% using 62% sucrose solution (2.351M sucrose, 3 mM Imi-
dazole pH 7.4) and 1 volume was loaded at the bottom of ultracentrifuge tubes.
Cushions of 35% sucrose (1.5 volume), 25% (1 volume) and 8% sucrose (1 volume)
were carefully added and the tubes were centrifuged at 210,000 × g for 3 h at 4 °C.
Gradients were divided in ten fractions and used either for immunoblotting or
immunopurification. Immunobloting was performed after sucrose gradient fractions
were concentrated following protein precipitation (25%/v TCA, incubated for 10
min at 4 °C, spun at 20,000 × g for 5 min at 4 °C; pellets were washed twice with
−20 °C pre-chilled acetone and air dried before resuspension in SDS sample buffer).
Selected sucrose gradient fractions were submitted to immunoprecipitation using an
anti-Endophilin antibody (mouse IgG2a/κ-ligh chain clone A-11, sc365704) coupled
directly to hydrazide-terminated magnetic beads (Bioclone Inc; coupling performed
following manufacturer’s instructions) to allow for elution of the binding material
without denaturation. Selected sucrose gradient fractions were adjusted to 500 µL
with HBA and incubated (overnight at 4 °C, slow rotation) with 1:50th volume of
anti-Endophilin coupled magnetic beads (pre-equilibrated in HBA with 250mM
sucrose). Unbound material was isolated, and the beads washed three times in 1mL
ice-cold HBB (washes were also kept for analysis). Bound material was released in
500mL elution buffer (0.1 M glycine pH 2, 250mM sucrose) for 10min (4 °C, slow
rotation), neutralized (>200 µL of 1M Tris pH 8 until pH back to neutral) and
prepared for immunoblotting. Lipids were analyzed by SDS-PAGE using Bis-Tris
gels run in MES buffer (to avoid excess counterions at the gel front that interfere
with lipid staining), and stained using alcohol-free coomassie (0.1% Coomassie in
10% acetic acid for 5 min and destained in water; alcohol was omited to not
solubilize the lipids out of the gels), as established previously45.
Immunoprecipitation for MS experiments. RPE1 cells were grown on 10 cm
dishes to a confluence of 80% before harvest. For stimulated condition, cell media
was supplemented with extra 10% FBS (20% final) for 5 min at 37 °C. For resting
condition, no additional treatment was performed prior to cell lysis. Cells were
washed two times in ice-cold PBS before being gently scraped into lysis buffer (10
mM Tris HCL pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP40 and a protease
and phosphatase inhibitor cocktail (Thermo Scientific)) and incubated on ice for
30 min, then centrifuged at 17,000×g for 10 min. Anti-endophilin antibodies
(Endophilin II A-11) were coupled in-house to hydrazide-terminated magnetic
beads (H-beads). Ten microliter of H-beads pre-washed in lysis buffer were
incubated with 470 µL of cell lysate overnight at 4 °C with end-over-end rotation.
The beads were washed three times in lysis buffer then boiled in 50 µL SDS sample
buffer for 10 min.
MS sample preparation by in-gel digestion. Samples were separated by SDS-
PAGE on a 4–12% gel and stained with InstantBlue (Expedeon) staining solution.
Sample lanes were cut into ten sections, then further cut into 1 mm3 pieces and
washed in destaining solution (40% ethanol, 10% glacial acetic acid in water).
Proteins were reduced in 10 mM DTT, then alkylated with 20 mM iodoacetamide
in 50 mM ammonium bicarbonate buffers. Gel pieces were washed then immersed
in a 10 ng/µL Trypsin buffer in 50 mM ammonium bicarbonate and digested for
16–18 h at 37 °C. Gel pieces were incubated in Elution buffer (1% formic acid, 2%
acetonitrile in LC-MS grade water (Thermo Scientific)) and dried in a SpeedVac.
Peptides resuspended in 0.5% acetic acid in water and desalted on C18-Stagetips,
then dried in a SpeedVac. Peptides were resuspended in LC-MS running buffer (3%
acetonitrile, 0.1% formic acid in water) prior to analysis by LC-MS and spiked with
E. coli ClpB peptides (Waters, UK) such that 50 fmol of spiked-in peptide standard
was introduced per injection.
Liquid chromatography and mass spectrometry data acquisition. LC-MS grade
solvents were used for all chromatographic steps. Separation of peptides was
performed using a Waters NanoAcquity Ultra-Performance Liquid Chromato-
graphy system. Peptides were reconstituted in 97:3 H2O:acetonitrile + 0.1% formic
acid. The mobile phase was: A) H2O+ 0.1% formic acid and B) Acetonitrile +
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0.1% formic acid. Desalting of the samples was performed online using a reversed-
phase C18 trapping column (180 µm internal diameter, 20 mm length, 5 µm par-
ticle size; Waters). Peptides were separated by a linear gradient (0.3 μL/min, 35 °C
column temperature; 97–60% Buffer A over 60 min) using an Acquity UPLC M-
Class Peptide BEH C18 column (130 Å pore size, 75 μm internal diameter, 250 mm
length, 1.7 μm particle size, Waters, UK). [Glu1]-fibrinopeptide B (GFP, Waters,
UK) was used as lockmass at 100 fmol/µL. Lockmass solution was delivered from
an auxiliary pump operating at 0.5 µL/min to a reference sprayer sampled every 60
s. The nanoLC was coupled online through a nanoflow sprayer to a QToF hybrid
mass spectrometer (Synapt G2-Si; Waters, UK). Accurate mass measurements were
made using a data-independent mode of acquisition (HDMSE). Each sample was
analyzed in technical duplicate.
Database searching and MS analysis. Raw data was analyzed using Progenesis
v4.0 (Waters, UK). Data were queried against a Homo sapiens FASTA protein
database (UniProt proteome:UP000005640) concatenated with a list of common
contaminants obtained from the Global Proteome Machine (ftp://ftp.thegpm.org/
fasta/cRAP) and E. coli ClpB, which acted as a standard for label-free absolute
protein quantitation67. Carbamidomethyl-C was specified as a fixed modification
and Oxidation (M) and Phosphorylation of STY were specified as variable mod-
ifications. A maximum of two missed cleavages were tolerated in the analysis to
account for incomplete digestion. For peptide identification three corresponding
fragment ions were set as a minimum criterion whereas for protein identification a
minimum of seven fragment ions were required. Protein false discovery rate was set
at 1%. Samples were normalized to Endophilin peptide abundance and fractions
were combined in-silico in Progenesis to obtain absolute protein abundances for
differential expression analysis.
Experimental design. A strategy for randomization, stratification, or blind selec-
tion of samples has not been carried out. Sample sizes were not chosen based on
pre-specified effect size. Instead, multiple independent experiments were carried
out using several independent biological replicates as detailed in the figure legends.
Quantification and statistical analysis. All experiments were repeated at least
three times, giving similar results. For all figures, results shown are mean ± stan-
dard error of the mean (SEM). Statistical testing was performed using Excel 14.7.3
(Microsoft) and Prism 6 (GraphPad Software). Comparisons of data were per-
formed by one-way analysis of variance (ANOVA) with Tukey’s multiple com-
parison test or by two-way ANOVA with Tukey’s multiple comparisons test, as
appropriated. NS, non significant (P > 0.05); *P < 0.05, **P < 0.01, ***P < 0.001.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
LC-MS/MS data have been deposited in ProteomeXchange Consortium via the PRIDE
partner repository with identifier PXD021138. All other data that support the findings of
this study are available from the corresponding author upon reasonable request. Source
data are provided with this paper.
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